Shahnaz P. Yusaf
GlaxoSmithKline (United Kingdom)(GB)Wellcome Sanger Institute(GB)
Publications by Year
Research Areas
Ion channel regulation and function, Neuroscience and Neuropharmacology Research, Cardiac electrophysiology and arrhythmias, Amino Acid Enzymes and Metabolism, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Measurement of the movement of the S4 segment during the activation of a voltage-gated potassium channel(1996)132 cited
- → Characterisation of 5‐HT3C, 5‐HT3Dand 5‐HT3Ereceptor subunits: evolution, distribution and function(2008)80 cited
- → Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of AMPA Receptor Positive Allosteric Modulators(2010)66 cited
- → Expression of voltage-gated calcium channel subunits in rat dorsal root ganglion neurons(2001)66 cited
- → Characterization of the human HCN1 channel and its inhibition by capsazepine(2004)53 cited
- → Streptozocin-Induced Neuropathy Is Associated with Altered Expression of Voltage-Gated Calcium Channel Subunit mRNAs in Rat Dorsal Root Ganglion Neurones(2001)51 cited
- → Discovery ofN-[(2S)-5-(6-Fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a Novel Clinical AMPA Receptor Positive Modulator(2010)47 cited
- → Structural Determinants of Drugs Acting on the Nav1.8 Channel(2009)35 cited
- → Effect of cysteine substitutions on the topology of the S4 segment of the Shaker potassium channel: implications for molecular models of gating(1999)33 cited
- → A panel of recombinant monoclonal antibodies against zebrafish neural receptors and secreted proteins suitable for wholemount immunostaining(2014)21 cited